Cleara Biotech Company
Dutch biotech company developing senescence-targeting therapeutics, including senolytics and senomorphics, to treat cancer and age-related diseases. Founded in 2018 in Utrecht, Netherlands, by researchers including Peter de Keizer. Cleara’s pipeline addresses cellular senescence as a driver of inflammation, fibrosis, and tumor progression. (clearabiotech.com)
Headquarters:
Yalelaan 62, 3584 CM Utrecht, Netherlands.
Founded Date:
2018
Estimated Revenue:
No public info